Announced Fri, 26 Jun · 19:53 IST
GTBL initiates arbitration against Optimus Drugs, claims about Rs 90 Cr for supply breach
Regulatory & Legal View source PDF
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹390.30
prior close
₹393.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-1.9-1.1+1.7+1.7+1.6-1.1-1.9-6.0-7.0———
Up moveDown movePending
AI summary
Gujarat Themis Biosyn has initiated arbitration against Optimus Drugs for terminating a supply agreement. The company claims about Rs 90.24 crore total: Rs 75 crore as break fees for breaching take-or-pay obligations, Rs 15 crore in damages and financial losses, and Rs 23.80 lakh as interest on delayed payments. GTBL expects no financial impact since it is the claimant seeking recovery.
Likely market impact
Positive if arbitration succeeds; potential recovery of about Rs 90 Cr but outcome is uncertain at this stage.